Patent details

EP1734997 Title: NATALIZUMAB FOR USE IN TREATING DISEASES NEEDING STEROID TREATMENT

Basic Information

Publication number:
EP1734997
PCT Application Number:
PCT/US/2005/010848
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP057682452
PCT Publication Number:
WO/2005/099776
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NATALIZUMAB FOR USE IN TREATING DISEASES NEEDING STEROID TREATMENT
French Title of Invention:
NATALIZUMAB ET SON UTILISATION DANS LE TRAITEMENT DES MALADIES NECESSITANTS DES CORTICOSTEROIDS.
German Title of Invention:
NATALIZUMAB ZUR VERWENDUNG BEI DER BEHANDLUNG VON KRANKHEITEN MIT KORTIKOSTEROID-THERAPIE
SPC Number:

Dates

Filing date:
30/03/2005
Grant date:
02/09/2015
EP Publication Date:
02/09/2015
PCT Publication Date:
27/10/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/12/2006
EP B1 Publication Date:
02/09/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
30/03/2025
Renunciation date:
Revocation date:
07/10/2024
Annulment date:

Owner

From:
29/09/2017
 
 

Name:
BIOGEN MA INC.
Address:
225 Binney Street, Cambridge, MA 02142, United States (US)

History of Owners

From:
06/02/2016
To:
29/09/2017

Name:
Biogen MA Inc.
Address:
250 Binney Street, Cambridge, MA 02142, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
11/11/2015
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
LIEBERBURG Ivan
Address:
United States (US)

Priority

Priority Number:
558120 P
Priority Date:
01/04/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 39/395;

Publication

Bulletin

Bulletin Heading:
VRV
Bulletin edition number:
2024/14
Publication date:
06/12/2024
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

1

Issue number:
202447
Publication date:
20/11/2024
Description:
Revocation of the European patent

2

Issue number:
201744
Publication date:
01/11/2017
Description:
Transfer of Rights

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
20/02/2024
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages